Late Adult Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Clinical Characterization and Predictors of Outcome (P7-8.005)
Alessandro Dinoto(University of Verona), Eoin P. Flanagan(Mayo Clinic in Arizona), Nisa Vorasoot(Khon Kaen University), Stephanie B. Syc‐Mazurek(Mayo Clinic), Eric Eggenberger(Michigan State University), Smathorn Thakolwiboon(Wheaton Franciscan Healthcare), Cristina Gutiérrez Valencia(WinnMed), Deena Tajfirouz(Anna Needs Neuroblastoma Answers), Nanthaya Tisavipat(Mayo Clinic in Arizona), Vyanka Redenbaugh(Mayo Clinic), Susan Horsman(WinnMed), Kevin D. Chodnicki(Mayo Clinic), Sean J. Pittock(Mayo Clinic), Kai Guo(Mayo Clinic), John Chen(Ankara Spine Center), Jan‐Mendelt Tillema, Laura Cacciaguerra(Vita-Salute San Raffaele University), Alfonso Lopez(WinnMed), Misha Pless
Cited by 1
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k
The spectrum of neuromyelitis optica
|The Lancet Neurology|2007|2.2k
Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis
|Annals of Neurology|2018|758